Industry: Pharma & Healthcare
Published Date: 2025-01-16
Pages: 94 Pages
Report ld: 3477670
Request Sample
Customized Report
Ampicillin Market Size(US$)

CAGR 2025-2031
2.6%
Market Size,2031
USD 208
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Ampicillin was estimated to be worth US$ 174 million in 2024 and is forecast to a readjusted size of US$ 208 million by 2031 with a CAGR of 2.6% during the forecast period 2025-2031.
Ampicillin is semisynthetic penicillin and a ß-lactam antibiotic, with Antimicrobial Spectrum of Effective against both Gram-positive (similar to benzylpenicillin) and Gram-negative bacteria (similar to tetracyclines and chloramphenicol).
China is the largest region of Ampicillin, with a market share nearly 70%. DSM, United Laboratories, CSPC Pharmaceutical, North China Pharmaceutical and Huaxing Pharmaceutical are the top 5 manufacturers of industry, and they had about 70% combined market share.
This report aims to provide a comprehensive presentation of the global market for Ampicillin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ampicillin by region & country, by Type, and by Application.
The Ampicillin market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ampicillin.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ampicillin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Ampicillin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Ampicillin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Ampicillin Product Introduction
1.2 Global Ampicillin Market Size Forecast
1.2.1 Global Ampicillin Sales Value (2020-2031)
1.2.2 Global Ampicillin Sales Volume (2020-2031)
1.2.3 Global Ampicillin Sales Price (2020-2031)
1.3 Ampicillin Market Trends & Drivers
1.3.1 Ampicillin Industry Trends
1.3.2 Ampicillin Market Drivers & Opportunity
1.3.3 Ampicillin Market Challenges
1.3.4 Ampicillin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Ampicillin Players Revenue Ranking (2024)
2.2 Global Ampicillin Revenue by Company (2020-2025)
2.3 Global Ampicillin Players Sales Volume Ranking (2024)
2.4 Global Ampicillin Sales Volume by Company Players (2020-2025)
2.5 Global Ampicillin Average Price by Company (2020-2025)
2.6 Key Manufacturers Ampicillin Manufacturing Base and Headquarters
2.7 Key Manufacturers Ampicillin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Ampicillin
2.9 Ampicillin Market Competitive Analysis
2.9.1 Ampicillin Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Ampicillin Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ampicillin as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Ampicillin Capsules
3.1.2 Ampicillin Sodium
3.1.3 Ampicillin Granules
3.1.4 Ampicillin Tablets
3.1.5 Ampicillin Sodium for Injection
3.1.6 Ampicillin Sodium and Sulbactam Sodium for Injection
3.1.7 Ampicillin Sodium and Cloxacillin Sodium for Injection
3.1.8 Others
3.2 Global Ampicillin Sales Value by Type
3.2.1 Global Ampicillin Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Ampicillin Sales Value, by Type (2020-2031)
3.2.3 Global Ampicillin Sales Value, by Type (%) (2020-2031)
3.3 Global Ampicillin Sales Volume by Type
3.3.1 Global Ampicillin Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Ampicillin Sales Volume, by Type (2020-2031)
3.3.3 Global Ampicillin Sales Volume, by Type (%) (2020-2031)
3.4 Global Ampicillin Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Adults
4.1.2 Kids
4.2 Global Ampicillin Sales Value by Application
4.2.1 Global Ampicillin Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Ampicillin Sales Value, by Application (2020-2031)
4.2.3 Global Ampicillin Sales Value, by Application (%) (2020-2031)
4.3 Global Ampicillin Sales Volume by Application
4.3.1 Global Ampicillin Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Ampicillin Sales Volume, by Application (2020-2031)
4.3.3 Global Ampicillin Sales Volume, by Application (%) (2020-2031)
4.4 Global Ampicillin Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Ampicillin Sales Value by Region
5.1.1 Global Ampicillin Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Ampicillin Sales Value by Region (2020-2025)
5.1.3 Global Ampicillin Sales Value by Region (2026-2031)
5.1.4 Global Ampicillin Sales Value by Region (%), (2020-2031)
5.2 Global Ampicillin Sales Volume by Region
5.2.1 Global Ampicillin Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Ampicillin Sales Volume by Region (2020-2025)
5.2.3 Global Ampicillin Sales Volume by Region (2026-2031)
5.2.4 Global Ampicillin Sales Volume by Region (%), (2020-2031)
5.3 Global Ampicillin Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Ampicillin Sales Value, 2020-2031
5.4.2 North America Ampicillin Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Ampicillin Sales Value, 2020-2031
5.5.2 Europe Ampicillin Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Ampicillin Sales Value, 2020-2031
5.6.2 Asia Pacific Ampicillin Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Ampicillin Sales Value, 2020-2031
5.7.2 South America Ampicillin Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Ampicillin Sales Value, 2020-2031
5.8.2 Middle East & Africa Ampicillin Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Ampicillin Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Ampicillin Sales Value
6.2.1 Key Countries/Regions Ampicillin Sales Value, 2020-2031
6.2.2 Key Countries/Regions Ampicillin Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Ampicillin Sales Value, 2020-2031
6.3.2 United States Ampicillin Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Ampicillin Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Ampicillin Sales Value, 2020-2031
6.4.2 Europe Ampicillin Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Ampicillin Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Ampicillin Sales Value, 2020-2031
6.5.2 China Ampicillin Sales Value by Type (%), 2024 VS 2031
6.5.3 China Ampicillin Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Ampicillin Sales Value, 2020-2031
6.6.2 Japan Ampicillin Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Ampicillin Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Ampicillin Sales Value, 2020-2031
6.7.2 South Korea Ampicillin Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Ampicillin Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Ampicillin Sales Value, 2020-2031
6.8.2 Southeast Asia Ampicillin Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Ampicillin Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Ampicillin Sales Value, 2020-2031
6.9.2 India Ampicillin Sales Value by Type (%), 2024 VS 2031
6.9.3 India Ampicillin Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 DSM
7.1.1 DSM Company Information
7.1.2 DSM Introduction and Business Overview
7.1.3 DSM Ampicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 DSM Ampicillin Product Offerings
7.1.5 DSM Recent Development
7.2 ACS Dobfar
7.2.1 ACS Dobfar Company Information
7.2.2 ACS Dobfar Introduction and Business Overview
7.2.3 ACS Dobfar Ampicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 ACS Dobfar Ampicillin Product Offerings
7.2.5 ACS Dobfar Recent Development
7.3 Kopran
7.3.1 Kopran Company Information
7.3.2 Kopran Introduction and Business Overview
7.3.3 Kopran Ampicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Kopran Ampicillin Product Offerings
7.3.5 Kopran Recent Development
7.4 Antibioticos
7.4.1 Antibioticos Company Information
7.4.2 Antibioticos Introduction and Business Overview
7.4.3 Antibioticos Ampicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Antibioticos Ampicillin Product Offerings
7.4.5 Antibioticos Recent Development
7.5 United Laboratories
7.5.1 United Laboratories Company Information
7.5.2 United Laboratories Introduction and Business Overview
7.5.3 United Laboratories Ampicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 United Laboratories Ampicillin Product Offerings
7.5.5 United Laboratories Recent Development
7.6 Shandong Lukang
7.6.1 Shandong Lukang Company Information
7.6.2 Shandong Lukang Introduction and Business Overview
7.6.3 Shandong Lukang Ampicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Shandong Lukang Ampicillin Product Offerings
7.6.5 Shandong Lukang Recent Development
7.7 CSPC Pharmaceutical
7.7.1 CSPC Pharmaceutical Company Information
7.7.2 CSPC Pharmaceutical Introduction and Business Overview
7.7.3 CSPC Pharmaceutical Ampicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 CSPC Pharmaceutical Ampicillin Product Offerings
7.7.5 CSPC Pharmaceutical Recent Development
7.8 North China Pharmaceutical
7.8.1 North China Pharmaceutical Company Information
7.8.2 North China Pharmaceutical Introduction and Business Overview
7.8.3 North China Pharmaceutical Ampicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 North China Pharmaceutical Ampicillin Product Offerings
7.8.5 North China Pharmaceutical Recent Development
7.9 Huaxing Pharmaceutical
7.9.1 Huaxing Pharmaceutical Company Information
7.9.2 Huaxing Pharmaceutical Introduction and Business Overview
7.9.3 Huaxing Pharmaceutical Ampicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Huaxing Pharmaceutical Ampicillin Product Offerings
7.9.5 Huaxing Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Ampicillin Industrial Chain
8.2 Ampicillin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Ampicillin Sales Model
8.5.2 Sales Channel
8.5.3 Ampicillin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Ampicillin market is projected to grow from US$ 178 million in 2025 to US$ 212 million by 2032, at a CAGR of 2.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-07-09
Pages: 152
USD 4900.00
(Single User License)
The global Ampicillin market size was US$ 178 million in 2025 and is forecast to reach a readjusted size of US$ 212 million by 2032 with a CAGR of 2.6% during the forecast period 2026-2032.
Published Date: 2026-07-09
Pages: 140
USD 4250.00
(Single User License)
The global Ampicillin market was valued at US$ 178 million in 2025 and is anticipated to reach US$ 212 million by 2032, at a CAGR of 2.6% from 2026 to 2032.
Published Date: 2026-07-09
Pages: 119
USD 2900.00
(Single User License)
The global market for Ampicillin was estimated to be worth US$ 178 million in 2025 and is projected to reach US$ 212 million, growing at a CAGR of 2.6% from 2026 to 2032.
Published Date: 2026-07-09
Pages: 136
USD 3950.00
(Single User License)
The global Ampicillin market is projected to grow from US$ 174 million in 2024 to US$ 208 million by 2031, at a CAGR of 2.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 147
USD 4900.00
(Single User License)
In 2024, the global market size of Ampicillin was estimated to be worth US$ 174 million and is forecast to reach approximately US$ 208 million by 2031 with a CAGR of 2.6% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 125
USD 5900.00
(Single User License)
The global Ampicillin market size was US$ 174 million in 2024 and is forecast to a readjusted size of US$ 208 million by 2031 with a CAGR of 2.6% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 78
USD 4250.00
(Single User License)
The global market for Ampicillin was valued at US$ 174 million in the year 2024 and is projected to reach a revised size of US$ 208 million by 2031, growing at a CAGR of 2.6% during the forecast period.
Published Date: 2025-01-16
Pages: 82
USD 2900.00
(Single User License)
Ampicillin is semisynthetic penicillin and a ß-lactam antibiotic, with Antimicrobial Spectrum of Effective against both Gram-positive (similar to benzylpenicillin) and Gram-negative bacteria (similar to tetracyclines and chloramphenicol).
Published Date: 2024-04-17
Pages: 143
USD 5600.00
(Single User License)
Ampicillin is semisynthetic penicillin and a ß-lactam antibiotic, with Antimicrobial Spectrum of Effective against both Gram-positive (similar to benzylpenicillin) and Gram-negative bacteria (similar to tetracyclines and chloramphenicol).
Published Date: 2024-04-16
Pages: 125
USD 5900.00
(Single User License)
The global Ampicillin market is projected to grow from US$ 178 million in 2025 to US$ 212 million by 2032, at a CAGR of 2.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-07-09
Pages: 152
The global Ampicillin market size was US$ 178 million in 2025 and is forecast to reach a readjusted size of US$ 212 million by 2032 with a CAGR of 2.6% during the forecast period 2026-2032.
Published: 2026-07-09
Pages: 140
The global Ampicillin market was valued at US$ 178 million in 2025 and is anticipated to reach US$ 212 million by 2032, at a CAGR of 2.6% from 2026 to 2032.
Published: 2026-07-09
Pages: 119
The global market for Ampicillin was estimated to be worth US$ 178 million in 2025 and is projected to reach US$ 212 million, growing at a CAGR of 2.6% from 2026 to 2032.
Published: 2026-07-09
Pages: 136
The global Ampicillin market is projected to grow from US$ 174 million in 2024 to US$ 208 million by 2031, at a CAGR of 2.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 147
In 2024, the global market size of Ampicillin was estimated to be worth US$ 174 million and is forecast to reach approximately US$ 208 million by 2031 with a CAGR of 2.6% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 125
The global Ampicillin market size was US$ 174 million in 2024 and is forecast to a readjusted size of US$ 208 million by 2031 with a CAGR of 2.6% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 78
The global market for Ampicillin was valued at US$ 174 million in the year 2024 and is projected to reach a revised size of US$ 208 million by 2031, growing at a CAGR of 2.6% during the forecast period.
Published: 2025-01-16
Pages: 82
Ampicillin is semisynthetic penicillin and a ß-lactam antibiotic, with Antimicrobial Spectrum of Effective against both Gram-positive (similar to benzylpenicillin) and Gram-negative bacteria (similar to tetracyclines and chloramphenicol).
Published: 2024-04-17
Pages: 143
Ampicillin is semisynthetic penicillin and a ß-lactam antibiotic, with Antimicrobial Spectrum of Effective against both Gram-positive (similar to benzylpenicillin) and Gram-negative bacteria (similar to tetracyclines and chloramphenicol).
Published: 2024-04-16
Pages: 125
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now